Pulished Date October, 2018
ID: 1196
Share on
Share on

Neurotherapeutics Market Segmented By Product, Type, Application, And Region - Global Growth, Trends, And Forecast To 2024

Pulished: October, 2018
ID: 1196
Pages: 182

The Neurotherapeutics Market was worth $ xxx Billion in 2018 and estimated to reach $ xxx Billion by the end of 2023 with a growing potential of xxx %.  

Neurologic disorders are defined as a change in the function of a nervous system. These are mainly caused due to structural change in activity of spinal cord, brain, and other nerves. These disorders are classified into three type’s namely Central nervous system disorders, Peripheral nervous system disorders, Autonomous nervous system disorders. These disorders involve progressive deterioration in mental and physical capabilities which disrupts the patient and patient’s family. Genetic disorders, brain injury, infections, congenital health problems and other traumas cause change in the brain activity which leads to various diseases such as Parkinson’s, neurological cancers, Alzheimer’s, Huntington’s disease, epilepsy etc. So, Neurotherapeutics are used for the treatment of traumas causing diseases. Some of the neurotherapeutic products that are in development phase includes MEM 3454, NS2330, 189254, MKC-231, IL-13-PE38, 737004, SLV308, CEP 1347, KW-6002, MT 100, MT 300, Phosiphen, and BIBN4096 BS.

The major factors that are driving the growth of the market are rise in the geriatric population, increasing R&D expenditure, increasing Health care expenditute, a better understanding of the nature of neurologic diseases.  As an increasing number of the aged population are more susceptible to brain disorders. Therefore, the rise in aging population and life expectancy of the people will increase the global neurotherapeutics market. The factors that are challenging the growth of the market are restrictions by regulatory bodies, lack of proper reimbursement policy, and lack of awareness in some developing countries.

Based on Treatment, the market is segmented into Neurologic drugs and Neurologic devices. Neurologic drugs are further classified into oral administration, injections and others. Whereas neurologic devices are further categorized into Electroconvulsive Therapy (ECT), Vagus Nerve Stimulation (VNS), transcranial magnetic stimulation, Deep Brain Stimulator, and others. Based on disorders, the market is segmented into Central Nervous system (CNS) disorders, Peripheral Nervous system (PNS) disorders, Autonomous Nervous system (ANS) disorders. Based on distribution channels the market is segmented into Hospitals, Neurotherapeutic center, Clinical research organizations, Clinics.

Based on Geography, the Neurotherapeutics market is analyzed under various regions namely North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America has the highest share in the market followed by Europe and Asia-Pacific due to the presence of top market players and also major technological advancements. Asia-Pacific is an emerging market due to many countries in this region are on the brink of strong economic growth (healthcare infrastructure, health facility up gradation and product expansion). These countries include Japan, China, India, Malaysia and Australia

Some of the major companies operating in global Neurotherapeutics Market are Abbott Laboratories, Inc., Becton, Novartis AG, Dickinson and Company, Pfizer, Inc., Johnson & Johnson, Biogen, Inc., GlaxoSmithKline, Inc., AstraZeneca plc, Sanofi-Aventis, Spiegelberg, stryker, Covidien, Medtronic, GE healthcare, and Merck & Co.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Treatment                  

                                5.1.1 Introduction           

                                5.1.2 Neurologic Drugs 

                                                5.1.2.1 Oral Administration

                                                5.1.2.2 Injections

                                                5.1.2.3 Others

                                5.1.3 Neurologic Devices             

                                                5.1.3.1 Electroconvulsive Therapy (ECT)

                                                5.1.3.2 Vagus Nerve Stimulation (VNS)

                                                5.1.3.3 Transcranial magnetic stimulation

                                                5.1.3.4 Deep Brain Stimulator

                                                5.1.3.5 Others

                                5.1.4 Y-o-Y Growth Analysis, By Product

                                5.1.5 Market Attractiveness Analysis, By Product               

                                5.1.6 Market Share Analysis, By Product                

                5.2 Disorders                    

                                5.2.1 Introduction           

                                5.2.2 Central Nervous system disorder  

                                5.2.3 Peripheral Nervous system disorder            

                                5.2.4 Autonomous Nervous system disorder       

                                5.2.5 Y-o-Y Growth Analysis, By Type      

                                5.2.6 Market Attractiveness Analysis, By Type     

                                5.2.7 Market Share Analysis, By Type      

                5.3 Distribution Channels                            

                                5.3.1 Introduction           

                                5.3.2 Hospitals  

                                5.3.3 Neurotherapeutic center  

                                5.3.4 Clinical Research organisations      

                                5.3.5 Clinics        

                                5.3.6 Y-o-Y Growth Analysis, By Application         

                                5.3.7 Market Attractiveness Analysis, By Application        

                                5.3.8 Market Share Analysis, By Application         

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Treatment

                                                6.1.3.3 By Disorders

                                                6.1.3.4 By Distribution Channels

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Treatment

                                                6.1.4.3 By Disorders

                                                6.1.4.4 By Distributional Channels

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Treatment

                                                6.1.5.3 By Disorders

                                                6.1.5.4 By Distribution channels

                6.2 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.3 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy           

                                6.2.6 France      

                6.4 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan        

                                6.3.5 Australia  

                                6.3.6 South Korea           

                6.5 Latin America                            

                                6.4.1 Introduction           

                                6.4.2 Brazil         

                                6.4.3 Argentina

                                6.4.4 Mexico     

                                6.4.5 Rest of Latin America         

                6.6 Middle East & Africa               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa        

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Abbott Laboratories               

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Becton                         

                8.3 Novartis AG                

                8.4 Dickinson and Company                       

                8.5 Pfizer                            

                8.6 Johnson & Johnson                 

                8.7 Biogen                          

                8.8 Glaxosmithkline                       

                8.9 AstraZeneca               

                8.10 Sanofi Aventis                        

                8.11 Spiegelberg                             

                8.12 Covidien                    

                8.13 Medtronic                

                8.14 GE Health Care                       

                8.15 Merck & Co                              

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Neurotherapeutics Market By Region, From 2019-2024 ( USD Billion )
  2. Global Neurotherapeutics Market By Treatment, From 2019-2024 ( USD Billion )
  3. Global Neurologic Drugs Market By Region, From 2019-2024 ( USD Billion )
  4. Global Neurologic Devices Market By Region, From 2019-2024 ( USD Billion )
  5. Global Neurotherapeutics Market By Disorders, From 2019-2024 ( USD Billion )
  6. Global Central Nervous system disorders Market By Region, From 2019-2024 ( USD Billion )
  7. Global Peripheral Nervous system disorders Market By Region, From 2019-2024 ( USD Billion )
  8. Global Autonomous Nervous system disorders Market By Region, From 2019-2024 ( USD Billion )
  9. Global Neurotherapeutics Market By Distribution Channels, From 2019-2024 ( USD Billion )
  10. Global Hospitals Market By Region, From 2019-2024 ( USD Billion )
  11. Global Neurotherapeutic center Market By Region, From 2019-2024 ( USD Billion )
  12. Global Clinical research organisations Market By Region, From 2019-2024 ( USD Billion )
  13. Global clinics Market By Region, From 2019-2024 ( USD Billion )
  14. Global Neurotherapeutics Market By Neurologic drugs, From 2019-2024 ( USD Billion )
  15. Global Oral Administrations Market By Region, From 2019-2024 ( USD Billion )
  16. Global Injections Market By Region, From 2019-2024 ( USD Billion )
  17. Global Neurotherapeutics Market By Neurologic devices, From 2019-2024 ( USD Billion )
  18. Global Electroconvulsive Therapy (ECT) Market By Region, From 2019-2024 ( USD Billion )
  19. Global Vagus Nerve Stimulation (VNS) Market By Region, From 2019-2024 ( USD Billion )
  20. Global Transcranial magnetic stimulation Market By Region, From 2019-2024 ( USD Billion )
  21. Global Deep Brain Stimulator Market By Region, From 2019-2024 ( USD Billion )
  22. North America Neurotherapeutics Market By Treatment, From 2019-2024 ( USD Billion )
  23. North America Neurologic Drugs Market By Region, From 2019-2024 ( USD Billion )
  24. North America Neurologic Devices Market By Region, From 2019-2024 ( USD Billion )
  25. North America Neurotherapeutics Market By Disorders, From 2019-2024 ( USD Billion )
  26. North America Central Nervous system disorders Market By Region, From 2019-2024 ( USD Billion )
  27. North America Peripheral Nervous system disorders Market By Region, From 2019-2024 ( USD Billion )
  28. North America Autonomous Nervous system disorders Market By Region, From 2019-2024 ( USD Billion )
  29. North America Neurotherapeutics Market By Distribution Channels, From 2019-2024 ( USD Billion )
  30. North America Hospitals Market By Region, From 2019-2024 ( USD Billion )
  31. North America Neurotherapeutic center Market By Region, From 2019-2024 ( USD Billion )
  32. North America Clinical research organisations Market By Region, From 2019-2024 ( USD Billion )
  33. North America clinics Market By Region, From 2019-2024 ( USD Billion )
  34. United States Neurotherapeutics Market By Treatment, From 2019-2024 ( USD Billion )
  35. United States Neurotherapeutics Market By Disorders, From 2019-2024 ( USD Billion )
  36. United States Neurotherapeutics Market By Distribution Channels, From 2019-2024 ( USD Billion )
  37. Canada Neurotherapeutics Market By Treatment, From 2019-2024 ( USD Billion )
  38. Canada Neurotherapeutics Market By Disorders, From 2019-2024 ( USD Billion )
  39. Canada Neurotherapeutics Market By Distribution Channels, From 2019-2024 ( USD Billion )
  40. North America Neurotherapeutics Market By Neurologic drugs, From 2019-2024 ( USD Billion )
  41. North America Oral Administrations Market By Region, From 2019-2024 ( USD Billion )
  42. North America Injections Market By Region, From 2019-2024 ( USD Billion )
  43. United States Neurotherapeutics Market By Neurologic drugs, From 2019-2024 ( USD Billion )
  44. Canada Neurotherapeutics Market By Neurologic drugs, From 2019-2024 ( USD Billion )
  45. North America Neurotherapeutics Market By Neurologic devices, From 2019-2024 ( USD Billion )
  46. North America Electroconvulsive Therapy (ECT) Market By Region, From 2019-2024 ( USD Billion )
  47. North America Vagus Nerve Stimulation (VNS) Market By Region, From 2019-2024 ( USD Billion )
  48. North America Transcranial magnetic stimulation Market By Region, From 2019-2024 ( USD Billion )
  49. North America Deep Brain Stimulator Market By Region, From 2019-2024 ( USD Billion )
  50. United States Neurotherapeutics Market By Neurologic devices, From 2019-2024 ( USD Billion )
  51. Canada Neurotherapeutics Market By Neurologic devices, From 2019-2024 ( USD Billion )
  52. Europe Neurotherapeutics Market By Treatment, From 2019-2024 ( USD Billion )
  53. Europe Neurologic Drugs Market By Region, From 2019-2024 ( USD Billion )
  54. Europe Neurologic Devices Market By Region, From 2019-2024 ( USD Billion )
  55. Europe Neurotherapeutics Market By Disorders, From 2019-2024 ( USD Billion )
  56. Europe Central Nervous system disorders Market By Region, From 2019-2024 ( USD Billion )
  57. Europe Peripheral Nervous system disorders Market By Region, From 2019-2024 ( USD Billion )
  58. Europe Autonomous Nervous system disorders Market By Region, From 2019-2024 ( USD Billion )
  59. Europe Neurotherapeutics Market By Distribution Channels, From 2019-2024 ( USD Billion )
  60. Europe Hospitals Market By Region, From 2019-2024 ( USD Billion )
  61. Europe Neurotherapeutic center Market By Region, From 2019-2024 ( USD Billion )
  62. Europe Clinical research organisations Market By Region, From 2019-2024 ( USD Billion )
  63. Europe clinics Market By Region, From 2019-2024 ( USD Billion )
  64. U.K. Neurotherapeutics Market By Treatment, From 2019-2024 ( USD Billion )
  65. U.K. Neurotherapeutics Market By Disorders, From 2019-2024 ( USD Billion )
  66. U.K. Neurotherapeutics Market By Distribution Channels, From 2019-2024 ( USD Billion )
  67. Germany Neurotherapeutics Market By Treatment, From 2019-2024 ( USD Billion )
  68. Germany Neurotherapeutics Market By Disorders, From 2019-2024 ( USD Billion )
  69. Germany Neurotherapeutics Market By Distribution Channels, From 2019-2024 ( USD Billion )
  70. France Neurotherapeutics Market By Treatment, From 2019-2024 ( USD Billion )
  71. France Neurotherapeutics Market By Disorders, From 2019-2024 ( USD Billion )
  72. France Neurotherapeutics Market By Distribution Channels, From 2019-2024 ( USD Billion )
  73. Italy Neurotherapeutics Market By Treatment, From 2019-2024 ( USD Billion )
  74. Italy Neurotherapeutics Market By Disorders, From 2019-2024 ( USD Billion )
  75. Italy Neurotherapeutics Market By Distribution Channels, From 2019-2024 ( USD Billion )
  76. Spain Neurotherapeutics Market By Treatment, From 2019-2024 ( USD Billion )
  77. Spain Neurotherapeutics Market By Disorders, From 2019-2024 ( USD Billion )
  78. Spain Neurotherapeutics Market By Distribution Channels, From 2019-2024 ( USD Billion )
  79. Europe Neurotherapeutics Market By Neurologic drugs, From 2019-2024 ( USD Billion )
  80. Europe Oral Administrations Market By Region, From 2019-2024 ( USD Billion )
  81. Europe Injections Market By Region, From 2019-2024 ( USD Billion )
  82. U.K. Neurotherapeutics Market By Neurologic drugs, From 2019-2024 ( USD Billion )
  83. Germany Neurotherapeutics Market By Neurologic drugs, From 2019-2024 ( USD Billion )
  84. France Neurotherapeutics Market By Neurologic drugs, From 2019-2024 ( USD Billion )
  85. Italy Neurotherapeutics Market By Neurologic drugs, From 2019-2024 ( USD Billion )
  86. Spain Neurotherapeutics Market By Neurologic drugs, From 2019-2024 ( USD Billion )
  87. Europe Neurotherapeutics Market By Neurologic devices, From 2019-2024 ( USD Billion )
  88. Europe Electroconvulsive Therapy (ECT) Market By Region, From 2019-2024 ( USD Billion )
  89. Europe Vagus Nerve Stimulation (VNS) Market By Region, From 2019-2024 ( USD Billion )
  90. Europe Transcranial magnetic stimulation Market By Region, From 2019-2024 ( USD Billion )
  91. Europe Deep Brain Stimulator Market By Region, From 2019-2024 ( USD Billion )
  92. U.K. Neurotherapeutics Market By Neurologic devices, From 2019-2024 ( USD Billion )
  93. Germany Neurotherapeutics Market By Neurologic devices, From 2019-2024 ( USD Billion )
  94. France Neurotherapeutics Market By Neurologic devices, From 2019-2024 ( USD Billion )
  95. Italy Neurotherapeutics Market By Neurologic devices, From 2019-2024 ( USD Billion )
  96. Spain Neurotherapeutics Market By Neurologic devices, From 2019-2024 ( USD Billion )
  97. Asia-Pacific Neurotherapeutics Market By Treatment, From 2019-2024 ( USD Billion )
  98. Asia-Pacific Neurologic Drugs Market By Region, From 2019-2024 ( USD Billion )
  99. Asia-Pacific Neurologic Devices Market By Region, From 2019-2024 ( USD Billion )
  100. Asia-Pacific Neurotherapeutics Market By Disorders, From 2019-2024 ( USD Billion )
  101. Asia-Pacific Central Nervous system disorders Market By Region, From 2019-2024 ( USD Billion )
  102. Asia-Pacific Peripheral Nervous system disorders Market By Region, From 2019-2024 ( USD Billion )
  103. Asia-Pacific Autonomous Nervous system disorders Market By Region, From 2019-2024 ( USD Billion )
  104. Asia-Pacific Neurotherapeutics Market By Distribution Channels, From 2019-2024 ( USD Billion )
  105. Asia-Pacific Hospitals Market By Region, From 2019-2024 ( USD Billion )
  106. Asia-Pacific Neurotherapeutic center Market By Region, From 2019-2024 ( USD Billion )
  107. Asia-Pacific Clinical research organisations Market By Region, From 2019-2024 ( USD Billion )
  108. Asia-Pacific clinics Market By Region, From 2019-2024 ( USD Billion )
  109. Japan Neurotherapeutics Market By Treatment, From 2019-2024 ( USD Billion )
  110. Japan Neurotherapeutics Market By Disorders, From 2019-2024 ( USD Billion )
  111. Japan Neurotherapeutics Market By Distribution Channels, From 2019-2024 ( USD Billion )
  112. China Neurotherapeutics Market By Treatment, From 2019-2024 ( USD Billion )
  113. China Neurotherapeutics Market By Disorders, From 2019-2024 ( USD Billion )
  114. China Neurotherapeutics Market By Distribution Channels, From 2019-2024 ( USD Billion )
  115. India Neurotherapeutics Market By Treatment, From 2019-2024 ( USD Billion )
  116. India Neurotherapeutics Market By Disorders, From 2019-2024 ( USD Billion )
  117. India Neurotherapeutics Market By Distribution Channels, From 2019-2024 ( USD Billion )
  118. Asia-Pacific Neurotherapeutics Market By Neurologic drugs, From 2019-2024 ( USD Billion )
  119. Asia-Pacific Oral Administrations Market By Region, From 2019-2024 ( USD Billion )
  120. Asia-Pacific Injections Market By Region, From 2019-2024 ( USD Billion )
  121. Japan Neurotherapeutics Market By Neurologic drugs, From 2019-2024 ( USD Billion )
  122. China Neurotherapeutics Market By Neurologic drugs, From 2019-2024 ( USD Billion )
  123. India Neurotherapeutics Market By Neurologic drugs, From 2019-2024 ( USD Billion )
  124. Asia-Pacific Neurotherapeutics Market By Neurologic devices, From 2019-2024 ( USD Billion )
  125. Asia-Pacific Electroconvulsive Therapy (ECT) Market By Region, From 2019-2024 ( USD Billion )
  126. Asia-Pacific Vagus Nerve Stimulation (VNS) Market By Region, From 2019-2024 ( USD Billion )
  127. Asia-Pacific Transcranial magnetic stimulation Market By Region, From 2019-2024 ( USD Billion )
  128. Asia-Pacific Deep Brain Stimulator Market By Region, From 2019-2024 ( USD Billion )
  129. Japan Neurotherapeutics Market By Neurologic devices, From 2019-2024 ( USD Billion )
  130. China Neurotherapeutics Market By Neurologic devices, From 2019-2024 ( USD Billion )
  131. India Neurotherapeutics Market By Neurologic devices, From 2019-2024 ( USD Billion )
  132. Latin America Neurotherapeutics Market By Treatment, From 2019-2024 ( USD Billion )
  133. Latin America Neurologic Drugs Market By Region, From 2019-2024 ( USD Billion )
  134. Latin America Neurologic Devices Market By Region, From 2019-2024 ( USD Billion )
  135. Latin America Neurotherapeutics Market By Disorders, From 2019-2024 ( USD Billion )
  136. Latin America Central Nervous system disorders Market By Region, From 2019-2024 ( USD Billion )
  137. Latin America Peripheral Nervous system disorders Market By Region, From 2019-2024 ( USD Billion )
  138. Latin America Autonomous Nervous system disorders Market By Region, From 2019-2024 ( USD Billion )
  139. Latin America Neurotherapeutics Market By Distribution Channels, From 2019-2024 ( USD Billion )
  140. Latin America Hospitals Market By Region, From 2019-2024 ( USD Billion )
  141. Latin America Neurotherapeutic center Market By Region, From 2019-2024 ( USD Billion )
  142. Latin America Clinical research organisations Market By Region, From 2019-2024 ( USD Billion )
  143. Latin America clinics Market By Region, From 2019-2024 ( USD Billion )
  144. Brazil Neurotherapeutics Market By Treatment, From 2019-2024 ( USD Billion )
  145. Brazil Neurotherapeutics Market By Disorders, From 2019-2024 ( USD Billion )
  146. Brazil Neurotherapeutics Market By Distribution Channels, From 2019-2024 ( USD Billion )
  147. Rest of Latin America Neurotherapeutics Market By Treatment, From 2019-2024 ( USD Billion )
  148. Rest of Latin America Neurotherapeutics Market By Disorders, From 2019-2024 ( USD Billion )
  149. Rest of Latin America Neurotherapeutics Market By Distribution Channels, From 2019-2024 ( USD Billion )
  150. Latin America Neurotherapeutics Market By Neurologic drugs, From 2019-2024 ( USD Billion )
  151. Latin America Oral Administrations Market By Region, From 2019-2024 ( USD Billion )
  152. Latin America Injections Market By Region, From 2019-2024 ( USD Billion )
  153. Brazil Neurotherapeutics Market By Neurologic drugs, From 2019-2024 ( USD Billion )
  154. Rest of Latin America Neurotherapeutics Market By Neurologic drugs, From 2019-2024 ( USD Billion )
  155. Latin America Neurotherapeutics Market By Neurologic devices, From 2019-2024 ( USD Billion )
  156. Latin America Electroconvulsive Therapy (ECT) Market By Region, From 2019-2024 ( USD Billion )
  157. Latin America Vagus Nerve Stimulation (VNS) Market By Region, From 2019-2024 ( USD Billion )
  158. Latin America Transcranial magnetic stimulation Market By Region, From 2019-2024 ( USD Billion )
  159. Latin America Deep Brain Stimulator Market By Region, From 2019-2024 ( USD Billion )
  160. Brazil Neurotherapeutics Market By Neurologic devices, From 2019-2024 ( USD Billion )
  161. Rest of Latin America Neurotherapeutics Market By Neurologic devices, From 2019-2024 ( USD Billion )
  162. Middle East & Africa Neurotherapeutics Market By Treatment, From 2019-2024 ( USD Billion )
  163. Middle East & Africa Neurologic Drugs Market By Region, From 2019-2024 ( USD Billion )
  164. Middle East & Africa Neurologic Devices Market By Region, From 2019-2024 ( USD Billion )
  165. Middle East & Africa Neurotherapeutics Market By Disorders, From 2019-2024 ( USD Billion )
  166. Middle East & Africa Central Nervous system disorders Market By Region, From 2019-2024 ( USD Billion )
  167. Middle East & Africa Peripheral Nervous system disorders Market By Region, From 2019-2024 ( USD Billion )
  168. Middle East & Africa Autonomous Nervous system disorders Market By Region, From 2019-2024 ( USD Billion )
  169. Middle East & Africa Neurotherapeutics Market By Distribution Channels, From 2019-2024 ( USD Billion )
  170. Middle East & Africa Hospitals Market By Region, From 2019-2024 ( USD Billion )
  171. Middle East & Africa Neurotherapeutic center Market By Region, From 2019-2024 ( USD Billion )
  172. Middle East & Africa Clinical research organisations Market By Region, From 2019-2024 ( USD Billion )
  173. Middle East & Africa clinics Market By Region, From 2019-2024 ( USD Billion )
  174. Middle East Neurotherapeutics Market By Treatment, From 2019-2024 ( USD Billion )
  175. Middle East Neurotherapeutics Market By Disorders, From 2019-2024 ( USD Billion )
  176. Middle East Neurotherapeutics Market By Distribution Channels, From 2019-2024 ( USD Billion )
  177. Africa Neurotherapeutics Market By Treatment, From 2019-2024 ( USD Billion )
  178. Africa Neurotherapeutics Market By Disorders, From 2019-2024 ( USD Billion )
  179. Africa Neurotherapeutics Market By Distribution Channels, From 2019-2024 ( USD Billion )
  180. Middle East & Africa Neurotherapeutics Market By Neurologic drugs, From 2019-2024 ( USD Billion )
  181. Middle East & Africa Oral Administrations Market By Region, From 2019-2024 ( USD Billion )
  182. Middle East & Africa Injections Market By Region, From 2019-2024 ( USD Billion )
  183. Middle East Neurotherapeutics Market By Neurologic drugs, From 2019-2024 ( USD Billion )
  184. Africa Neurotherapeutics Market By Neurologic drugs, From 2019-2024 ( USD Billion )
  185. Middle East & Africa Neurotherapeutics Market By Neurologic devices, From 2019-2024 ( USD Billion )
  186. Middle East & Africa Electroconvulsive Therapy (ECT) Market By Region, From 2019-2024 ( USD Billion )
  187. Middle East & Africa Vagus Nerve Stimulation (VNS) Market By Region, From 2019-2024 ( USD Billion )
  188. Middle East & Africa Transcranial magnetic stimulation Market By Region, From 2019-2024 ( USD Billion )
  189. Middle East & Africa Deep Brain Stimulator Market By Region, From 2019-2024 ( USD Billion )
  190. Middle East Neurotherapeutics Market By Neurologic devices, From 2019-2024 ( USD Billion )
  191. Africa Neurotherapeutics Market By Neurologic devices, From 2019-2024 ( USD Billion )

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients

Research Areas